Andes Virus Travel Health Alert
Overview
Andes virus is a species of hantavirus naturally present in Argentina and Chile. This virus is carried by infected rodents, particularly the long-tailed pygmy rice rat (Oligoryzomys longicaudatus) in South America. Human infection occurs through inhalation of aerosolized virus particles from contaminated rodent excreta, urine, or saliva—not through direct rodent bites.
Geographic Distribution
Andes virus transmission is endemic to:
- Argentina: Primarily southern regions
- Chile: Predominantly southern territories
Risk areas typically include rural, forested, and agricultural regions where rodent populations thrive.
Clinical Significance
Andes virus causes Hantavirus Pulmonary Syndrome (HPS), a severe respiratory illness with high mortality rates (approximately 35-40%). Initial symptoms include fever, myalgia, headache, and gastrointestinal complaints, progressing to respiratory distress and potential cardiopulmonary failure within 1-2 weeks of exposure.
Traveler Precautions
- Avoid contact with rodents, their droppings, and contaminated materials
- Do not enter abandoned buildings, caves, or areas with visible rodent activity
- When camping or staying in rural accommodations, seal food containers and maintain clean living spaces
- Wear protective equipment (N95 masks, gloves) when cleaning areas with potential rodent contamination
- Seek immediate medical attention if respiratory symptoms develop within 45 days of potential exposure
Medical Considerations
No specific antiviral therapy exists for hantavirus infection. Management focuses on supportive care and early hospitalization. Early recognition and intensive respiratory support significantly improve outcomes.
Pharmacist's note: While no preventive medications exist for Andes virus, travelers should ensure routine vaccinations are current before departure. If respiratory symptoms develop post-travel, inform healthcare providers of potential hantavirus exposure and rodent contact history. Delayed diagnosis remains a significant challenge; clinical suspicion is critical for early intervention.
Additional Resources
For current information, consult the CDC travel health notices and contact travel medicine providers before departure to Argentina or Chile.